{"id":"incadronic-acid","rwe":[{"pmid":"32245019","year":"2020","title":"Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products.","finding":"","journal":"Molecules (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"28208725","year":"2017","title":"Reaction of 3-Amino-1,2,4-Triazole with Diethyl Phosphite and Triethyl Orthoformate: Acid-Base Properties and Antiosteoporotic Activities of the Products.","finding":"","journal":"Molecules (Basel, Switzerland)","studyType":"Clinical Study"}],"tags":[{"label":"incadronic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Farnesyl pyrophosphate synthase","category":"target"},{"label":"FDPS","category":"gene"},{"label":"Active","category":"status"},{"label":"Humoral hypercalcemia of malignancy","category":"indication"},{"label":"Osteoporosis","category":"indication"},{"label":"Astellas","category":"company"},{"label":"Bone Density Conservation Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Astellas Pharma","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=INCADRONIC ACID","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:47.340567+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:53.923784+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=INCADRONIC ACID","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:54.342211+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL53950/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:55.544970+00:00"}},"allNames":"bisphonal","offLabel":[],"synonyms":["YM-21175-1","bisphonal","incadronic acid","cimadronate","cimadronic acid","icandronate","incadronate","incadronate disodium hydrate","incadronate disodium","YM-175","YM175"],"timeline":[{"date":"1997-01-01","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Astellas)"}],"approvals":[{"date":"1997-01-01","orphan":false,"company":"Astellas","regulator":"PMDA"}],"brandName":"Bisphonal","ecosystem":[{"indication":"Humoral hypercalcemia of malignancy","otherDrugs":[{"name":"betamethasone","slug":"betamethasone","company":""},{"name":"betamethasone acetate","slug":"betamethasone-acetate","company":""},{"name":"cortisone acetate","slug":"cortisone-acetate","company":""},{"name":"dexamethasone","slug":"dexamethasone","company":""}],"globalPrevalence":null},{"indication":"Osteoporosis","otherDrugs":[{"name":"abaloparatide","slug":"abaloparatide","company":"Radius Health Inc"},{"name":"calcium citrate","slug":"calcium-citrate","company":""},{"name":"calcium gluconate","slug":"calcium-gluconate","company":""},{"name":"calcium phosphate","slug":"calcium-phosphate","company":""}],"globalPrevalence":200000000}],"mechanism":{"target":"Farnesyl pyrophosphate synthase","targets":[{"gene":"FDPS","source":"DrugCentral","target":"Farnesyl pyrophosphate synthase","protein":"Farnesyl pyrophosphate synthase"}],"modality":"Small Molecule","drugClass":"incadronic acid","explanation":"","oneSentence":"","technicalDetail":"Bisphosphonate specifically inhibits the enzyme farnesyl pyrophosphate synthase, which is a key regulator of mevalonate pathway, leading to the inhibition of osteoclast activity and subsequent reduction in bone resorption."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1431","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=INCADRONIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:57:56.675899","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:57.263643+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"alendronic acid","drugSlug":"alendronic-acid","fdaApproval":"1995-09-29","relationship":"same-target"},{"drugName":"pamidronic acid","drugSlug":"pamidronic-acid","fdaApproval":"1991-10-31","relationship":"same-target"},{"drugName":"risedronic acid","drugSlug":"risedronic-acid","fdaApproval":"1998-03-27","relationship":"same-target"},{"drugName":"zoledronic acid","drugSlug":"zoledronic-acid","fdaApproval":"2001-08-20","patentExpiry":"Feb 5, 2028","patentStatus":"Patent protected","relationship":"same-target"}],"genericName":"incadronic acid","indications":{"approved":[{"name":"Humoral hypercalcemia of malignancy","source":"DrugCentral","snomedId":47709007,"regulator":"FDA"},{"name":"Osteoporosis","source":"DrugCentral","snomedId":64859006,"regulator":"FDA","usPrevalence":10000000,"globalPrevalence":200000000,"prevalenceMethod":"curated","prevalenceSource":"IOF, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"alendronic-acid","brandName":"alendronic acid","genericName":"alendronic acid","approvalYear":"1995","relationship":"same-target"},{"drugId":"pamidronic-acid","brandName":"pamidronic acid","genericName":"pamidronic acid","approvalYear":"1991","relationship":"same-target"},{"drugId":"risedronic-acid","brandName":"risedronic acid","genericName":"risedronic acid","approvalYear":"1998","relationship":"same-target"},{"drugId":"zoledronic-acid","brandName":"zoledronic acid","genericName":"zoledronic acid","approvalYear":"2001","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"G5C4M8847E","CHEBI":"CHEBI:135189","INN_ID":"7122","UMLSCUI":"C1881172","chemblId":"CHEMBL53950","ChEMBL_ID":"CHEMBL53950","KEGG_DRUG":"D08073","DRUGBANK_ID":"DB06255","PUBCHEM_CID":"3699","IUPHAR_LIGAND_ID":"3174","SECONDARY_CAS_RN":"138330-18-4","MESH_SUPPLEMENTAL_RECORD_UI":"C071542"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Astellas","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.82 hours","clearance":"2.16 mL/min/kg","bioavailability":"1%","fractionUnbound":"0.9%","volumeOfDistribution":"0.24 L/kg"},"publicationCount":2,"therapeuticAreas":["Bone"],"biosimilarFilings":[],"recentPublications":[{"date":"2020 Mar 20","pmid":"32245019","title":"Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products.","journal":"Molecules (Basel, Switzerland)"},{"date":"2017 Feb 8","pmid":"28208725","title":"Reaction of 3-Amino-1,2,4-Triazole with Diethyl Phosphite and Triethyl Orthoformate: Acid-Base Properties and Antiosteoporotic Activities of the Products.","journal":"Molecules (Basel, Switzerland)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Astellas Pharma","companyId":"astellas","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"1997-01-01T00:00:00.000Z","mah":"Astellas","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:57.263643+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}